Interest in GLP-1 medications has grown rapidly, and with that growth has come an increase in organizations offering prescriptions through online platforms. GLP-1 telehealth has created new opportunities for patients to access care, particularly for those who face transportation barriers or limited provider availability. The reality is that convenience should never come at the expense of patient safety, regulatory compliance, or sound clinical judgment.

The demand for GLP-1 medications continues to grow, and with that growth comes a new set of operational and regulatory challenges for healthcare organizations. While much of the public conversation centers on patient access and clinical outcomes, compliance professionals are spending more time evaluating the compliance concerns regarding GLP-1s that can affect prescribing practices, documentation, reimbursement, marketing, and organizational oversight.